Physician profile
Daniel Morris
NPI 1346336856
$3,529.68
in general payments reported to CMS, 2019-2025
42 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $176 · 2021: $656 · 2022: $792 · 2023: $613 · 2024: $419 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $614.40 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $531.20 | 2019-2025 | Belbuca, Xtampza |
| Averitas Pharma INC. | $337.82 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $242.57 | 2021-2022 | |
| Saluda Medical Americas, INC. | $202.26 | 2023-2025 | Evoke Scs, Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.58 | 2021-2025 | Relistor |
| Abbvie INC. | $161.28 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $134.31 | 2019-2022 | |
| Saol Therapeutics INC. | $126.55 | 2020 | |
| Abbott Laboratories | $107.43 | 2020-2023 | Eterna |
| Spr Therapeutics, INC | $87.57 | 2022 | |
| Arbor Pharmaceuticals, INC. | $69.63 | 2020-2021 | |
| Sentynl Therapeutics, INC. | $59.37 | 2019 | |
| Merck Sharp & Dohme LLC | $56.81 | 2022-2023 | Belsomra |
| Lilly USA, LLC | $40.83 | 2019-2023 | Reyvow, Emgality |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.